Advertisement

Newsline


Tuesday, December 20, 2011

Physicians at Jefferson Hospital to Use New Immunotherapy on Brain Tumor Patients

Jefferson Hospital for Neuroscience (JHN) physicians are tackling a particularly aggressive brain cancer that even surgery, chemotherapy and radiation often fail to treat with a promising new immunotherapy to attack a patient’s tumor with their own …
Click here to read more

Monday, December 19, 2011

New Drug Candidate May Halt Decline of Alzheimer’s Sufferers

The drug, referred to as J147, improved memory and prevented brain damage caused by the disease when given to mice with Alzheimer’s. Developed by scientists at the Salk Institute for Biological Studies, the compound could be tested for treatment of …
Click here to read more

Monday, December 19, 2011

Magnetic Stimulation of the Brain May Aid in Recovery of Certain Stroke Patients

Magnetic stimulation of the nerve cells in the brain may speed up recovery from hemispatial neglect, a condition in which patients wake up and are unable to see or recognize anything on the left side of their bodies, according to a new study. The findings …
Click here to read more

Friday, December 16, 2011

Researchers Discover Hyper-active Protein in the Brain

According to researchers, 40–60 percent of a common but deadly type of brain tumor called glioblastoma multiforme (GBM) have mutations in a gene that encodes a protein known as an epidermal growth factor receptor (EGFR). These mutations result in hyper …
Click here to read more

Friday, December 16, 2011

Widespread Brain Atrophy Detected in Cognitively Impaired Parkinson’s Patients

Atrophy in the hippocampus, the region of the brain known for memory formation and storage, is evident in Parkinson’s disease (PD) patients who have cognitive impairment, including early decline known as mild cognitive impairment (MCI), according to …
Click here to read more

Thursday, December 15, 2011

Researchers Design Antibodies Aimed at Combatting Alzheimer’s

Researchers at the Rensselaer Polytechnic Institute, Troy, N.Y., have developed a new method for designing antibodies that are aimed at combating disease. The surprisingly simple process was used to produce antibodies that neutralize the harmful protein …
Click here to read more

Wednesday, December 14, 2011

The Brain on Trial: Neuroscience and the Law

How insights about the brain affect the course of a criminal trial, from the arguments in a courtroom to the issuing of a sentence, was the topic of the Fred Kavli Public Symposium, held recently at the Society for Neuroscience's “Neuroscience …
Click here to read more

Tuesday, December 13, 2011

Ecstasy Drug Can Cause Chronic Changes in the Brain

Vanderbilt University investigators have discovered that recreational use of Ecstasy — the illegal “rave” drug that causes feelings of euphoria and emotional warmth — is associated with chronic changes in the human brain. The findings, reported …
Click here to read more

Monday, December 12, 2011

Study Shows That Multiple Sclerosis May Start in Brain’s Outer Layers

Multiple sclerosis (MS) may progress from the outermost layers of the brain to its deep parts and isn’t always an inside-out process, as previously thought, according to a collaborative study from researchers at the Mayo and Cleveland clinics. It’ …
Click here to read more

Friday, December 9, 2011

Researchers Create First Realistic 3D Diagram of the Brain’s Cortical Column

Researchers from the lab of Nobel Laureate Bert Sakmann, MD, PhD, at the Max Planck Florida Institute (MPFI) say they have created the first realistic 3D diagram of a thalamocortical column in the rodent brain through the use of a conceptually new approach …
Click here to read more